Boundless Bio, Inc.

NasdaqGS:BOLD Stock Report

Market Cap: US$59.8m

Boundless Bio Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:BOLD Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Apr 24BuyUS$5,000,000RA Capital Management, L.P.Company312,500US$16.00
02 Apr 24BuyUS$3,200,000Arch Venture Partners, L.P.Company200,000US$16.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BOLD?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders390,5901.75%
Public Companies1,615,2017.24%
General Public2,818,66912.6%
VC/PE Firms6,102,79527.4%
Institutions11,371,30751%

Dilution of Shares: BOLD only recently listed within the past 12 months


Top Shareholders

Top 25 shareholders own 85.18% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15%
FMR LLC
3,338,084US$8.9m0%no data
12.1%
Arch Venture Partners, L.P.
2,694,095US$7.2m0%1.05%
9.78%
RA Capital Management, L.P.
2,180,631US$5.8m0%0.07%
7.24%
Bayer Aktiengesellschaft
1,615,201US$4.3m0%no data
5.51%
Nextech Invest Ltd.
1,228,069US$3.3m0%0.56%
4.59%
Redmile Group, LLC
1,023,548US$2.7m-1.07%0.16%
4.25%
Wellington Management Group LLP
947,612US$2.5m-0.08%no data
4.23%
Vertex Venture Management Pte. Ltd.
942,455US$2.5m0%100.0%
3.22%
Citadel Advisors LLC
718,527US$1.9m0%no data
3.19%
Tavistock Life Sciences
711,329US$1.9m0%0.14%
3.04%
Sectoral Asset Management Inc.
678,574US$1.8m-0.54%0.35%
2.47%
City Hill Ventures, LLC
550,915US$1.5m0%100.0%
1.83%
BlackRock, Inc.
408,686US$1.1m-21%no data
1.35%
Alyeska Investment Group, L.P.
300,000US$804.0k0%no data
1.18%
The Vanguard Group, Inc.
264,211US$708.1k182%no data
1.15%
Zachary Hornby
256,410US$687.2k0%no data
1.08%
PFM Health Sciences, LP
240,513US$644.6k71.2%0.04%
0.84%
Ensign Peak Advisors, Inc.
187,500US$502.5k-48.6%no data
0.73%
Sio Capital Management, LLC
162,058US$434.3k0%0.21%
0.71%
Norges Bank Investment Management
157,211US$421.3k0%no data
0.52%
Geode Capital Management, LLC
116,627US$312.6k5.42%no data
0.46%
Jonathan Lim
102,564US$274.9k0%no data
0.26%
Logos Global Management, L.P.
58,903US$157.9k-50%0.02%
0.26%
Northern Trust Global Investments
57,578US$154.3k0%no data
0.24%
UBS O'Connor LLC
53,168US$142.5k0%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 01:58
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Boundless Bio, Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Chris ShibutaniGoldman Sachs
Michael SchmidtGuggenheim Securities, LLC
Andrew BerensLeerink Partners LLC